B7-H3-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)
$3,246,139FY2020Defense Health AgencyDOD
The General Hospital Corporation
Investigators
View source on USAspending →B7-H3-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC) · GrantIndex